Search
Paul Wynn
Fabian Agel
Matthias Knotzer
Dr. Birgit Leimer
Katharina Walter
Médard Schoenmaeckers
Dr. Birgit Leimer
Heidi De Wit-Sommerfeld
Facts About Asthma
Respimat media
Respimat media
Trust Through Transparency
EFPIA disclosure
.
Living Independence
Boehringer Ingelheim’s corporate culture is based on values that have been applied since the company was founded in 1885.
Speak up
We are committed to conducting business with integrity and in compliance with applicable laws, regulations, company policies and procedures.
OUR FOCUS
Our FOCUS is the cultural framework for our company. It describes who we are and what we strive for, why we exist, how we work and what we want to achieve.
The Angels Initiative – F.A.S.T.
The Angels initiative, stroke symptoms, giving life a chance, optimizing stroke care
BI Access to Healthcare Strategy_Availability
Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Global Code of Conduct
Boehringer Ingelheim´s Global Code of Conduct
Cardiometabolic Research
Read about our patient-centric approach to cardiometabolic disease research.
Making more health through animal health
Boehringer Ingelheim and Ashoka aim to build a world with a greater access to health for people, animals and their communities.
Green Chemistry
Green Chemistry is critical for us as it balance the long-term sustainability of business, society, and the environment.
CENTRAGARD internal parasite protection for cats in US
Centragard, an innovative product to treat heartworm disease in cats, launched in the U.S.
FDA approves NexGard for the prevention Lyme disease in dogs
Boehringer Ingelheim received approval from the U.S. (FDA) to expand the label claims for NexGard, the chewable flea and tick product.
Randye’s Story
Randye Kaye’s son, Ben, has schizophrenia. In this video we hear about her experiences and hopes for brain research, as she talks to Dr Michael Sand from Boehringer Ingelheim